SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-19-007969
Filing Date
2019-02-13
Accepted
2019-02-13 16:54:20
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G a19-4593_1sc13g.htm SC 13G 64645
  Complete submission text file 0001104659-19-007969.txt   66169
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES INC (Filed by) CIK: 0000882095 (see all company filings)

IRS No.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Subject) CIK: 0001737287 (see all company filings)

IRS No.: 823562771 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90685 | Film No.: 19598300
SIC: 2836 Biological Products, (No Diagnostic Substances)